ArticleThoracic cancer2022

The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer.

Da Hyun Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.